Skip to content

Estimation of antibodies in saliva and blood against coronavirus after COVID-19 vaccination

Estimation of the salivary and serum IgA antibodies post COVID-19 vaccination: a cross-sectional study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/04/041945
Enrollment
288
Registered
2022-04-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NIl: Nil Control Intervention1: Nil: Nil

Sponsors

Manipal Centre for Infectious diseases Manipal Seed Fund
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Human participants (healthy volunteers or patients coming to Manipal College of Dental Sciences, Manipal or Kasturba Medical college /Hospitals, who have received the two doses of COVID19 vaccination (Covaxin or Covishield) and volunteer to participate after oral and written informed consent will be included Participants should be between the ages of 18-60 years

Exclusion criteria

Exclusion criteria: Participants who are not vaccinated will be excluded Participants who have received the 2nd dose of Covishield or Covaxin 2 week before will be excluded. Participants presenting with any immunocompromised condition, genetic abnormalities related to IgA, pregnant and lactating females; patients undergoing any chemotherapy, radiation therapy; Patients on corticosteroids, antiviral therapy, immunomodulators will be excluded.

Design outcomes

Primary

MeasureTime frame
Mean serum and salivary IgA levels.Timepoint: Baseline

Secondary

MeasureTime frame
Age, gender, smoking status, oral hygiene status as calculated by patients Oral Hygiene index-simplified, DMF, presence of any other systemic diseases, and comorbidities.Timepoint: baseline

Countries

India

Contacts

Public ContactAditi Chopra

Manipal College of Dental Sciences, Manipal

draditichopra@gmail.com08202922173

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026